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SUMMARY
NOVAK, R. F. & SWIFT, T. J. (1976) Nuclear magnetic resonance studies of barbitur-
ate-phospho!ipid interactions. Mol. Pharmacol., 12, 263-278.
Interactions between phenobarbita! or pentobarbita! with the phospholipids phosphati-
dylcholine, sphingomyelin, phosphatidylethanolamine, and cardiolipin were indicated
by the effects of added phospholipid on the ‘H magnetic resonance spectra of these
barbiturates. Similar studies with phosphatidylsenine gave no indication of interaction
between phospholipid and the barbiturates at a comparable phospholipid concentration.
Of the two barbiturates studies, phenobarbita! produced the greater spectral change at a
given phospholipid to barbiturate ratio. The interactions of the barbiturates with the
phospholipids were further characterized using 31p and ‘3C magnetic resonance. Addi-
tion of barbiturate to phospholipid produced marked upfield shifts in the respective 3P
peaks of the phospholipids. ‘3C studies verified that protonation of the basic phosphate
group of the phospholipids by the weakly acidic N -H proton of the barbiturate did not
account for the observed spectral changes. The direction, magnitude, and temperature
dependence of the observed changes in chemical shifts in the proton and phosphorus
magnetic resonance spectra are consistent with hydrogen bonding as the mode of
association of the barbiturates with the phospholipids. These studies specifically identi-
fied the molecular sites of interaction as an N -H moiety of the barbiturate and the
phosphate group of the phospholipid, and allowed determination of the association
constants for the interactions in chloroform: Kass,,c for the various barbiturate-phospho-
lipid pairs ranged from 175 to 25, the latter value corresponding to the phosphatidyletha-
nolamine-phenobarbita! interaction. The results are discussed in terms of a model for
the interaction of barbiturates with membranes.
INTRODUCTION
A large number of drugs, especially
those affecting the central nervous system,
e.g., the barbiturates, require a considera-
ble degree of membrane permeability on
membrane solubility to achieve the de-
sired clinical effect. Barbitunic acid itself
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produces no anesthetic effect, and it is only
with the addition of various substituents
in the C-S position (Fig. 1) that it derives
its general depressant nature. The phar-
macological properties of the barbiturates
have been related to their membrane solu-
bility (i.e., the more highly membrane-
soluble compounds are the shorter-acting
agents with a rapid onset of action) (1).
Since the barbiturates exist in signifi-
cant concentrations in both ionized and
un-ionized forms at pH 7 in aqueous me-
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FIG. 1. Barbiturate and phospholipid structures
which form is responsible for anesthetic
action. Clowes et al. (2), evaluating the
effect of pH change in both extracellulan
and intracellular phases on the potency of
barbiturates in inhibiting cell division of
fertilized eggs and movement of the larvae
of Arbacia, concluded that the uncharged
form of the barbiturate was responsible for
anesthetic action. Blaustein (3), however,
using giant axons of the lobster, found that
pentobarbital, when applied extracellu-
larly, was more effective in blocking the
action potential at external pH 8.5 than at
pH 6.7 and concluded that the anionic form
of pentobanbital was the active form. In
contrast, Krupp et al. (4) observed that
both pentobarbital and phenobanbital
were more effective at external pH 6.8
than at pH 8.8 in blocking the action po-
tential of demye!inated frog nerve. Fun-
then studies by Narahashi et al. (5), using
internally and externally perfused squid
giant axon, support the conclusion that
pentobarbital blocks the action potential
in the unchanged molecular form.
Models presented for ion flow in excita-
ble membranes postulate that the polar
groups of phospholipids may undergo con-
figurational transitions producing changes
in membrane permeability and nerve
function (6-8). Certain agents have been
demonstrated to influence cation permea-
bility of lipid bi!ayen model systems (9),
and the barbiturates have been demon-
strated to affect the electrical properties of
nerve in vitro (3-5). While Blaustein and
Goldman (10) have suggested a possible
drug-phospholipid complex, no investiga-
tion of these interactions on a molecular
level has been made. If barbiturates are
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active in the unchanged form, as experi-
ments of Knupp et al. (4) and Narahashi et
al. (5) have indicated, then one mechanism
of drug-membrane interaction might be
complex formation with phospholipids
through a combination of hydrogen bond-
ing and hydrophobic interactions.
‘H, 3’P, and ‘3C magnetic resonance
spectnoscopy has been employed to investi-
gate directly the nature and strength of
barbiturate-phospholipid interactions as a
model for possible drug-membrane inter-
actions. While the membrane itself is am-
phipathic and exposed to water at its hy-
drophilic surfaces, the interior is nela-
tively nonpolar and hydrophobic in na-
tune. These studies were conducted using a
weakly polar medium, chloroform, in or-
der to simulate the internal polarity of the
membrane, as well as to provide optimal
conditions for observing an interaction by
nuclear magnetic resonance spectnoscopy.
To investigate the possibility of an interac-
tion occurring between barbiturates and
phospholipids in a more polar environ-
ment such as water, a “wet” phospholipid
(one in which the water concentration was
5 times the concentration of the phospho-
lipid) was made, and banbitunate-phospho-
lipid association was demonstrated. While
experimental requirements preclude in-
vestigation of this phenomenon in a totally
aqueous environment, the wet phospho-
lipid approach was taken to demonstrate
that association can in fact occur in an
environment containing a considerable
concentration of water.
MATERIALS AND METHODS
Phenobarbital was purchased from
Merck and used without further purifica-
tion. Pentobarbital was obtained from K &
K Laboratories as the sodium salt and con-
verted to the acid form. The sodium pento-
barbital was dissolved in distilled water
and acidified with nitric acid before extrac-
tion with chloroform. The pentobanbital
was purified by recrystallization from hot
water. Tri-n-butyl phosphate was obtained
from Fisher and used without purification.
An alcoholic solution of sodium hydroxide
was prepared by the addition of sodium
hydroxide to anhydnous ethanol. The con-
centration of the resulting solution was
determined by titration. Phosphatidyleth-
anolamine (bacteria) was purchased from
Calbiochem. Phosphatidylcholine (egg)
and sphingomyelin (bovine brain) were
purchased from Sigma Chemical Com-
pany. Cardiolipin (bovine brain) and phos-
phatidylsenine (bovine brain) were ordered
specially prepared in the acid form from
Applied Science Laboratories. The purity
of these phospholipids was checked by
thin-layer chromatography on silica gel
plates, using solvent systems composed of
CHC1:,CH:30HH20 (70:30:4) and CHC1:1
CH3OH-CH3CO2H-H20 (75:25:5:2) ( 1 1).
The compounds were located by iodine va-
por on by ashing with an H2S04 solution
saturated with Na2Cr2O7. Each method
produced a single, well-defined, darkened
area. Thin-layer chromatography per-
formed on samples after completion of
NMR experiments showed virtually no de-
composition.
The experimental solutions were pre-
pared with deutenochlonoform (Diapnep)
which had been dried oven molecular
sieves. A ‘H Fourier transform spectrum
of the CDC1:3 was taken to check the purity
of the solvent. After 300 acquisitions no
signals other than CHC13 were present.
All solutions were stoned over molecular
sieves (type 4A, Fisher) for at least 2 days
prior to use.
The “wet” phospholipid was made by ad-
dition of aliquots of deionized water to a
solution of phospholipid in chloroform un-
til the desired concentration ratio of H20
to phospholipid was achieved. No change
in the physical characteristics of the solu-
tion were observed.
The 31p spectra of the phospholipids in
deuterochlonoform were recorded at 24.3
MHz on a Vanian HA 60 spectrometer
equipped with a probe which accepts 15-
mm sample tubes and is modified for
Fourier transform technique. A 20% solu-
tion of tetraethylammonium phosphate
(pH 10-12) contained in a concentric 4.5-
mm NMR tube served as an external lock
standard. The observed changes in the 31p
chemical shift are reported in parts per
million and are considered accurate to
±0.1 ppm.
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The  ‘ P variable-temperature studies
were performed on the Vanian HA 60 in-
strument using 12-mm sample tubes; tem-
peratunes were measured to ± 1#{176}.The
changes in chemical shift as a function of
increasing temperature are reported for
phosphatidylcholine in Hertz, using a 20%
solution of phosphoric acid as the external
lock standard.2’ ‘ The addition of banbitur-
ate to phosphatidylcholine sufficiently
shifted the 31P peak upfield to allow the
use of a 20% phosphoric acid lock. Phos-
phonic acid does not shift appreciably with
temperature (5 Hz over the temperature
range 30-60#{176})as determined by measuring
the change in chemical shift of the 20%
phosphoric acid lock with a solution of 0.4
M tni-n-butyl phosphate in carbon tetra-
chloride; therefore the downfield shift of
the complexed phosphatidylcholine peak
with increasing temperature could be ob-
tained. Teflon inserts were used in the 15-
mm and 12-mm NMR tubes to assure that
the external lock remained centrally lo-
cated while spinning. The direction, val-
ues, and thermal effects of all 31p studies
were verified using the Vanian XL 100
spectrometer openatin, in the 3’P Fourier
transform mode at 40.5 MHz. Spectra ob-
tained were proton-decoupled, and the in-
strument was locked internally on the sig-
nal from deuterochioroform. Tempera-
2 Although the accepted convention for reporting
3’P chemical shifts is to use 85% phosphoric acid as a
standard, the experimental conditions imposed by
the Fourier transform technique and instrumenta-
tion as well as the observed 3’P chemical shift of the
samples precluded use of 85% phosphoric acid as the
external lock standard.
Tetraethylammonium phosphate was also
tested in the temperature study; however, the 31p
peak of this standard shifted dramatically with tem-
perature as determined against a 0.4 M solution of
tri-n-butyl phosphate in carbon tetrachloride. How-
ever, when the known values for the shift of tetra-
ethylammonium phosphate as a function of temper-
ature were established, a standard curve could be
constructed. When this chemical shift was taken
into consideration in measuring the difference in the
downfield shift of the phosphatidylcholine peak as a
function of temperature, the values were essentially
the same as those determined with respect to the
20% phosphoric acid reference (differences in &
Hz).
tunes were measured directly to ± 1#{176}in the
probe with a thermometer.
The ‘H magnetic resonance results were
recorded at 60 MHz and 100 MHz using
Vanian A 60A and HA 100 spectrometers,
respectively. Shifts are reported downfield
from tetramethylsilane, the internal refer-
ence, in pants pen million, with an accu-
racy of ±0.03 ppm. Variable-temperature
studies were performed using the A 60A
spectrometer, and temperatures were
measured to ±1#{176}.
‘3C studies were performed with a Van-
ian XL 100 spectrometer operating at 23.5
MHz in the Fourier transform mode. The
instrument was locked internally on the
deutenium signal from deutenochlorofonm,
with the ‘3C deutenochlonoform signal
serving as the internal reference. Changes
in chemical shifts are reported in parts per
million, with the negative sign indicating
a downfield shift from CDC13.
Treatment of data. The nonlinearity of
the 31p plots of the change in chemical
shift vs. increasing concentration of bar-
biturates allows stability constants to be
calculated. The method by which these
stability constants may be calculated em-
ploys the following equation (12, 13):
&)bS = X0li0 + (1 - Xa)tSb
where  and b represent the chemical
shift in parts pen million of the unasso-
ciated species and the complexed species,
respectively, and x represents the mole
fraction of nuclei that are not complexed.
If the changes in chemical shift which oc-
cur as a result of complexation are meas-
ured from the peak of the free species, then
6a can be taken as the reference point and
set equal to zero. The equation now re-
duces to
obs = (1 - Xa)b = XbIJb
where Xb is the mole fraction of complexed
nuclei.
The association constant Ka (assum-
ing a 1:1 complex) is given by
Kass,c =
[C]
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where C is defined as the concentration of
the phospholipid-barbiturate complex. It is
possible via a reiterative procedure to
evaluate Kassoc and 6b By using various
stability constant values and values of 6b
a reasonable fit of the data points may be
obtained. The results of these calculations
for the systems phosphatidylcholine-phe-
nobarbital, phosphatidylcholine-pentobar-
bital, sphingomyelin-phenobarbita!, and
sphingomyelin-pentobarbital are given in
Table 1, and typical examples of the curve
fit obtained are shown in Fig. SA, B, and
C. These results are summarized in Table
1.
RESULTS
‘H NMR studies. Proton magnetic reso-
nance spectra of certain barbiturates in
CDC13 have been reported previously (14,
15). Phenobanbital (0.04 M) gives a PMR
spectrum consisting of a singlet at 6 8.2,
indicative of protons bound to the ring ni-
trogen atoms. The pheny! group gives rise
to a singlet at 6 7.4, with the ethyl substit-
uent producing a quartet at 6 2.6 and a
triplet at 6 1.0. The PMR spectrum of pen-
tobarbital (0.04 M) has a singlet at 6 8.2
produced by the protons of ring-bound ni-
trogen, as well as signals of various multi-
plicities in the range 1-2 ppm resulting
from the ethyl and 1-methylbutyl substitu-
ents.
The chemical shift of the signal corre-
sponding to the protons attached to the
nitrogen atoms of the ring varies with
temperature and solvent; as the polarity of
the solvent increases, the position of the
N -H peak is shifted downfield (15, 16).
The self-association constants of phenobar-
bital and pentobanbital in CDC13 are 8.1
M’ and 7.0 M’, respectively (16).
Calculation of the dimer concentration in 0.04 M
phenobarbital and 0.04 M pentobarbital gives a
value of about approximately 8 mM; 20% of 0.04 M
barbiturate exists as dimers. While these concentra-
tions of dimers may be present, it is not necessary to
add an additional term to the first equation. The
contribution of such a term would be small, since
Addition of aliquots of phosphatidylcho-
line (0.11 M) and sphingomyelin (0.045 M)
in CDC13 to a solution of0.04 M pentobanbi-
tal in CDC13 produced significant line
bnoadeninW and a considerable downfield
shift in the N -H peak of the barbiturate,
with no change in the remainder of the
spectrum. A plot of the chemical shift of
the N -H peak of phenobarbital against
the concentration of phosphatidy!choline
and sphingomyelin is given in Fig. 2A and
B. A phosphatidy!choline to phenobarbital
concentration ratio of 1:1 corresponds to a
1.9-ppm downfield shift of the N -H sig-
nal, while a 1:1 ratio of phosphatidylcho-
line to pentobarbital gives a shift of 0.9
ppm (Fig. 2A and B). Similarly, for sphin-
gomyelin-phenobarbital and sphingomye-
lin-pentobanbital at unity concentration
ratios, downfield shifts of 1.9 ppm and 0.9
ppm, respectively, were measured (Fig. 2A
and B).
Addition of aliquots of 0.03 M candiolipin
(acid form) to samples of 0.04 M phenobar-
bital and 0.04 M pentobarbital produced
large downfield shifts with signal broaden-
ing. At a concentration ratio of cardiolipin
to phenobanbita! of 0.43, a downfield shift
of 1.4 ppm was observed, while the corre-
sponding ratio of candiolipin to pentobanbi-
tal gave a 0.9-ppm shift (Fig. 2A and B).
Addition of aliquots of 0.07 M phosphati-
dylsenine (acid form) to 0.04 M phenobanbi-
tal produced virtually no changes in line-
width on chemical shift of the barbiturate
 for the barbiturate-phospholipid complex is
larger than that for dimer formation.
Quantitative data on linewidth changes of the
N-H peak with addition of the phospholipids phos-
phatidylcholine, sphingomyelin, and cardiolipin
were not determined. These linewidth changes may
occur as the result of chemical exchange of the bar-
biturate between the free and complexed species, or
may be due to additional ‘4N quadrupolar relaxation
effects arising from complexation of the barbiturate.
These changes are more difficult to monitor accu-
rately and are not as dramatic as the changes occur-
ring in chemical shift. In the case of phosphatidyl-
ethanolamine, however, quantitative data were de-
termined, since the linewidth changes, measured at
100 MHz, caused by addition of this phospholipid
were marked, changing by a factor of 5 over a small
concentration range; these changes were the princi-
pal manifestation of the interaction in this case.


















“Estimated error in these values is approximately ± 10%.
b0 is the limiting chemical shift value for the fully complexed species.
N -H peak. Addition of aliquots of 0.03 M
phosphatidylethanolamine to a solution of
0.04 M phenobarbital produced considena-
ble line broadening and a small downfield
shift of the N -H peak. A plot of the
change in chemical shift of the phenobar-
bital N -H peak against increasing phos-
phatidylethanolamine concentration is
given in Fig. 2A (inset). The full linewidth
at half-maximum of the barbiturate N -H
peak with addition of phosphatidyletha-
nolamine changed by a factor of approxi-
mately 5, going from about 5.6 Hz to 25.6
Hz (at 100 MHz) at a relatively small phos-
phatidylethanolamine to barbiturate ratio
of 0.1. Aliquots of 3.65 M tni-n-butyl phos-
phate added to solutions of 0.04 M pheno-
barbital and 0.04 M pentobarbital also re-
sulted in large downfield shifts of 2.1 ppm
and 1.9 ppm, respectively, at a tni-n-butyl
phosphate to barbiturate ratio of 34.5.
However, it is important to note that the
concentration of tni-n-butyl phosphate was
considerably larger (i.e., 100-fold) than
that reached in the cases of phospho!ipid
additions. At a barbiturate to phospholipid
concentration ratio of 0.1, the change in
the N -H !inewidth upon the addition of
phosphatidylcholine, sphingomyelin, car-
diolipin, or tni-n-butyl phosphate was neg-
ligible compared to that observed for the
phosphatidylethanolamine-phenobarbital
5
Hydrogen bonding in PMR is character-
ized by a downfield shift and displays a
marked temperature dependence, the
peak shifting back toward the non-hydro-
gen-bonded position with increasing tem-
perature, i.e., upfield (17). As noted above,
the N -H peak of the barbiturates was
shifted downfield with the addition of
phospholipid or tni-n-butyl phosphate. The
effect of temperature was monitored over
the range 34-65#{176},and the results were sim-
ilar for all the reactant pains. For example,
the temperature dependence of the barbi-
turate-phosphatidylcho!ine interaction is
given in Fig. 3, where the log ofthe change
in chemical shift of the N -H peak is plot-
ted against reciprocal temperature. The
upfield shift produced by the 30#{176}increase
in temperature was 30 Hz (0.5 ppm) for
phosphatidylcholine-phenobarbital at a
concentration ratio of 0.4, and 8 Hz (0.08
ppm) for phosphatidy!ethanolamine-phe-
nobarbital at a concentration ratio of 0.1.
The slopes were virtually identical for all
the barbiturate-phospholipid pains at var-
ious concentration ratios, thus indicating
that the LJI values of formation of the
complexes were all approximately equal.
This result might be expected, since hy-
drogen bond formation typically yields MI
values of 2-10 kca!/mole (18).
31p NMR studies. In order to investigate
the involvement of the phosphate moiety
of the phospholipids in the interaction
with the barbiturates, 31p magnetic reso-
nance studies were conducted. The 3P
chemical shift of phosphatidylcholine is
approximately 3 ppm (75 Hz) upfield from
the signal of a 20% solution of tetraethyl-
ammonium phosphate (external refer-
ence), while those of sphingomyelin and
phosphatidylethanolamine are approxi-
mately 2 ppm (45 Hz) and 2.6 ppm (63 Hz),
respectively. Some approximate values for
the 3’P signal positions of the phospholip-
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FIG. 2. Change in chemical shift of the barbiturates phenobarbital (A) and pentobarbital (B) as a function
of increasing concentration of cardiolipin (A), sphingomyelin (0), phosphatidylcholine (, and phosphati-
dylethanolamine (0, inset in A)
The concentration of barbiturates used was 0.04 M, the maximum solubility of phenobarbital in chloro-
form.
ids as related to a solution of 20% phos-
phoric acid are: phosphatidylcho!ine,
about 0 ppm; sphingomyelin, about -1
ppm; phosphatidylethanolamine, about
-0.6 ppm. A typical spectrum of 0.045 M
phosphatidylcholine is given in Fig. 4.
Addition of weighed amounts of solid
phenobarbital on aliquots of a 0.04 M solu-
tion of pentobarbital to a solution of 0.11 M
and 0.045 M phosphatidylcholine or 0.045 M
sphingomyelin produced significant up-
field shifts in the phosphorus peaks of the
phospholipids. There was virtually no
change in the spin coupling constant JPH of
phosphatidylcho!ine. A plot of the chemi-
cal shift of the “P peak of phosphatidyl-
choline against increasing concentrations
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FIG. 3. Chemical shift temperature dependence
a. Typical change in the N -H chemical shift
(upfield) for the systems phosphatidylcholine-phe-
nobarbital (#{149})and phosphatidylcholine-pentobarbi-
tal (0) with increasing temperature. The concentra-
tions of phosphatidylcholine in the phosphatidylcho-
line-phenobarbital and phosphatidylcholine-pento-
barbital systems were 14 and 31 mrt, respectively.
b. Downfield change in the 31P chemical shift of
0.11 M phosphatidylcholine, 68 ms in phenobarbital
(0) and 150 ms in pentobarbital (#{149}),as a result of
increasing temperature.
given in Fig. 5A and B; the corresponding
plot for the addition of phenobarbital and
pentobarbital to sphingomyelin is given in
Fig. 5C. Addition of weighed amounts of
phenobarbital to 7 m.i cardiolipin pro-
duced a small upfield shift of the cardio-
lipin 31P peak (Fig. 5D). This shift is much
less than that observed for phosphatidyl-
choline on sphingomyelin because of the
concentration difference as well as the
state of the phosphate group in the phos-
pholipid. The phospholipid structures are
presented in Fig. 1.
Addition of weighed amounts of pheno-
barbital to a solution of 0.03 M phosphati-
dylethanolamine produced a small shift of
the phosphorus peak (Fig. 5D), while the
addition of phenobarbital to tri-n-butyl
phosphate solution produced virtually no
change in position of the “P peak.6
FIG. 4. 3’P Fourier transform spectrum of 0.045
M phosphatidylcholine consisting of a peak split into
five components with spin coupling constant J,,, of 7
Hz
The large peak occurring at 0 ppm is the 3’P lock/
reference signal of tetraethylammonium phosphate.
The direction of the 31P chemical shifts
might be the result typically expected for
protonation of a phosphate ester group and
could be verified by comparison with the
31P titration curve of the phosphate groups
in ATP in aqueous media (19, 20). Since
our studies were performed in nonaqueous
media, it was necessary to document that
the same qualitative change occurred for
protonation of phosphates in a weakly po-
lar solvent such as chloroform. This was
accomplished by the addition of aliquots of
glacial acetic acid to solutions of 0.045 M
phosphatidylcho!ine, 0.045 M sphingomye-
lin, 0.03 M phosphatidylethanolamine, and
0.365 M tni-n-butyl phosphate.
If phosphatidylcholine and sphingomye-
lin in CDC13 solution do contain ionized
phosphate groups, as suggested (21, 22),
the chemical shift should occur in an up-
ton decoupling, the concentration of tri-n-butyl
phosphate was necessarily much greater than the
concentration of phenobarbital, 0.365 M vs. 0.04 M,
and therefore no significant shift was observed.
RATIO Pchol / Phenobarbutal





Phenobarbital X 10 M
RATIO Pcho / Pentobarbital
2.2 1.1 0.76 0.56 0.45
5.5 2.8 1.8 1.4 1.1 0.9
I I I 1
B
20 40 60 80 100 120
Pentobarbital X 1OM
RATIO Phospholipd/5obituote
035 0.18 0.12 0.09 (107 0.06 (.o.-o.3










20 40 60 80 100 120
D
10 20 30 40 50 60 70 80 900 110120
Barbiturate X 10’3M Phenoborbitol 5 103M
FIG. 5. Upfield change in “P chemical shift of phospholipids as a function of increasing barbiturate
concentration
A and B. Change in the 3’P chemical shift of 0.11 M (Ls) and 0.045 M (#{149})phosphatidylcholine (PChol) with
increasing concentrations of phenobarbital (A) and pentobarbital (B). +, b values calculated from the
association constants (Table 1) and data fit obtained for the phosphatidylcholine-phenobarbital and phos-
phatidylcholine-pentobarbital complexes. (0) change in 3’P chemical shift of hydrated phosphatidylcholine
(0.045 M phosphatidylcholine containing 0.225 M H20) upon addition of phenobarbital.
C. Upfield change in the “P chemical shift of 0.045 M sphingomyelin with the addition of phenobarbital
(#{149})and pentobarbital (0). + andU, 8 values obtained from the association constants of sphingomyelin-
phenobarbital and sphingomyelin-pentobarbital, respectively (Table 1).
D. Upfield change in the ‘P chemical shift of 7 mi cardiolipin (0) and 0.03 M phosphatidylethanol-



























field direction as a result of addition of
acetic acid and the observed 6 value of
these phospholipids should be much
greaten than that of tni-n-butyl phosphate,
which contains a neutral phosphate group.
This was in fact observed. The results are
illustrated in Fig. 6A and B, with phos-
phatidylcholine and sphingomyelin pro-
ducing the greatest z6, upfield, in agree-
ment with protonation studies conducted
in aqueous media (19, 20).
In addition to determination of specific
sites and mechanisms of association, it
was also possible to evaluate the associa-
tion constant (Kass) for the phospholipid-
barbiturate pairs. The 31P concentration
plots were nonlinear, and the shift ap-
peared to approach a limiting value, which
allowed stability constants to be calculated
for these systems (13). These values were
determined, and ranged from 175 for
sphingomylin-phenobanbital to 25 for
phosphatidylethanolamine - phenobarbital
(Table 1).
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RATIO Phospholipid /Acetic Acid
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Acetic Acid X 1O3M
RATIO Tri-n-butyl phosphate/ Acetic Acid
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FIG. 6. Effects of acetic acid upon 31p spectra of phospholipids and tri-n-butyl ph.3sphate
A. Upfield change in 31p chemical shift of the phospholipids phosphatidylcholine (0.045 M) (0), sphingo-
myelin (0.045 M) (#{149}),and phosphatidylethanolamine (0.03 M (0) with increasing concentration of acetic acid.











To support the conclusion that hydrogen
bonding is responsible for the upfield
shifts, a temperature study was conducted.
The phosphorus peak was shifted upfleld
by the addition of phenobanbital or pento-
barbital, and the temperature was in-
creased over the range 30-65#{176}.The result
of increasing the temperature was a down-
field shift of the phosphorus peak in a
manner reflective of hydrogen bond dis-
ruption. The downfield shifts of the phos-
phatidylcholine-phenobarbital and phos-
phatidylcholine-pentobarbital solutions
with increasing temperature are shown in
Fig. 3. The temperature study conducted
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downfield shift of approximately 5 Hz. No
31p temperature studies were performed on
phosphatidylethanolamine-barbiturate or
cardiolipin-barbiturate solutions.
Since chloroform was used as the weakly
polar medium to study barbiturate-phos-
pholipid interactions, it was also desirable
to investigate the association of barbitur-
ate with phospholipids in the presence of
some water, such as might exist at the
surface of the membrane. A system con-
sisting of phosphatidylcholine and water
in chloroform was used.
Figure 5A shows that despite the pres-
ence of water (at 5 times the concentration
of phosphatidylcholine), additions of phe-
nobarbital to this system produced upfield
shifts in the 31P peak of the phospholipid.
These shifts were on the order of 0.5 ppm
(12 Hz) at a phosphatidylcholine to pheno-
barbital concentration ratio of unity, dem-
onstrating that barbiturate-phospholipid
association occurred even in the presence
of an excess of water.
‘3C NMR studies. The direction of the
31J) chemical shift produced by the addition
of barbiturate was upfield, similar to that
of protonation of phosphate groups in the
ATP molecule (19, 20). Since the ionized
phosphate group, reported to exist in phos-
phatidyicholine and sphingomyelin (21,
22), is a very basic site and may be capable
of abstracting a proton from the barbitur-
ate, it was necessary to verify that the
observed ‘H or 3’P chemical shift changes
were not the result of proton transfer. This
was checked using “C magnetic reso-
nance. A 0.1 M pentobarbital solution
was titrated by the addition of aliquots of a
1.0 M solution of sodium hydroxide in
ethanol. The results (Fig. 7) show that the
‘3C downfield shifts obtained for the car-
bonyl position at a sodium hydroxide to
pentobarbital concentration ratio of ap-
proximately 1 as a result of deprotonation
of the barbiturate were very large (13-14
ppm). This demonstrates that if a proton is
removed from an N -H group in the barbi-
turate, the corresponding increase in
charge results in a large downfield shift of
the signal corresponding to the carbonyl
carbon. Hence, if the phosphate group is
20 40 60 80 100 120
Sodurn hydrcsde
FIG. 7. Change in I3(’ chemical shift in carbonyl
groups of pentobarbital (carbonyl group 2, U; car-
bonyl groups 4 and 6, #{149})(Fig. 1) with addition of
alcoholic sodium hydroxide
+, change in the ‘3C carbonyl chemical shift with
the addition of the phospholipid phosphatidylcholine
at concentrations equal to those of the alcoholic
sodium hydroxide.
basic enough to remove the proton, a large
‘3C downfield shift of the canbonyl signal
should occur with the addition of phospha-
tidylcholine to barbiturate.
Addition of aliquots of 0.1 M phosphati-
dylcholine to 0.1 M pentobarbital up to a
phosphatidylcholine to pentobarbital ratio
of 1:2 produced a small ‘3C chemical shift
of the carbonyl groups (0.5 ppm) (Fig. 7).
These observed changes in chemical shift
were too small to have resulted from the
deprotonation of the barbiturate and may
have been due to hydrogen bonding of the
N -H moiety to the phospholipid.
DISCUSSION
The proton magnetic resonance studies
show that a hydrogen bonding interaction
may have occurred between the barbitu-
rates and phosphatidylcholine, sphingo-
myelin, cardiolipin, phosphatidylethanol-
amine, and tni-n-butyl phosphate; in addi-
tion, virtually no interaction was indi-
cated between the barbiturates and phos-
phatidylsenine at comparable concentra-
tions. One rationale for the failure to ob-
serve any interaction between phosphati-
dylsenine and barbiturates is that the
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although another possibility might be (intermolecu-
lar)
higher concentrations of phosphatidylsen-
me would be required. In all cases the
observed downfield shift of the N -H peak
of pentobarbital was markedly less than
that of phenobarbital. This can be pre-
dicted from pK(, values of the two barbitu-
rates studied. The pK(, values of phenobar-
bital and pentobarbital are 7.3 and 8.0,
respectively (23), and hence the observa-
tion that pentobanbital produces smaller
shifts than phenobarbital is consistent
with the ability of these barbiturates to
serve as proton donors. Clearly the ionized
phosphate group provides a basic site that
might be expected to participate in hydro-
gen bonding. However, it becomes neces-
sary to consider these shifts and linewidth
changes as possibly resulting from interac-
tions not directly related to formation of a
banbiturate-phospholipid complex. In-
frared studies have shown that phosphati-
dylcholine and sphingomyelin exist in an
ionic form, characteristic of a dipolar ion
or internal salt, in a nonaqueous medium
such as CC14, and have 1 strongly associ-
ated water molecule per molecule of phos-
pholipid (21, 22). Candiolipin was ordered
specially prepared in the acid form; the
state of phosphatidylethanolamine was
less well defined.7 Since the position of the
The exact nature of the ionic structure of phos-
phatidylethanolamine in a weakly polar solvent
would seem at present to be a somewhat controver-
sial issue. Chapman et al. (24, 25) have interpreted
their PMR data and the infrared data of Abramson
et al. (22) as being suggestive of the existence of a -
-NH3 group in phosphatidylethanolamine. Other
authors (21, 26), however, have reported infrared
data indicating that the phosphate group in phos-
phatidylethanolamine exists in the un-ionized form.
A structure for phosphatidylethanolamine was sug-
gested by Abramson et al. (22) with this phospholipid
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associated water peak on P - OH peak was
not observed in PMR, possibly because of
0 H
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A more recent publication by Akutsu and Kyo-
goku (27), using infrared and Raman spectroscopy,
indicated that phosphatidylethanolamine exists in a
dipolar ionic form in tetrachloroethylene and carbon
disulfide solutions. Our “P NMR results show that
the phosphate group in phosphatidylethanolamine
is not the same as the phosphate groups in phospha-
tidylcholine or sphingomyelin. For example, addi-
tion of acetic acid to phosphatidylcholine or sphingo-
myelin in CDC13 gives a total shift of approximately
2.0 ppm at a concentration ratio of 0.32, while a
concentration ratio of 0.21 produces a shift of only
about 0.8 ppm in phosphatidylethanolamine. The
addition of acetic acid to tri-n-butyl phosphate (a
neutral phosphate) in CDC13 produces a change in
chemical shift of approximately 0.6 ppm at a concen-
tration ratio of 0.21.
Since 31p NMR directly monitors the phosphate
group, one would conclude that the phosphate group
of phosphatidylethanolamine appears to be different
from that of phosphatidylcholine or sphingomyelin.
This difference may be due to several factors, such
as the ionic state of the phosphate group or the
micellar structure of the phospholipid. Our interpre-
tation of the data would be to suggest that phospha-
tidylethanolamine exists in solution either in a non-
ionic form (A) or in a strongly intra- or intermolecu-
larly hydrogen-bonded complex (B or C).
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severe broadening or masking by the pro-
ton spectra of the phospholipid, the ob-
served downfield shifts and linewidth
changes could merely be reflective of, or
contain a sizable contribution from, an ex-
change process (28). Such exchange proc-
esses may be present in the observed
changes of proton chemical shifts upon ad-
dition of cardiolipin or phosphatidyletha-
nolamine to barbiturate (Fig. 2A and B).
The PMR results might also be indicative
of hydrogen bonding between the barbitur-
ate and water strongly associated with the
phospholipid. While the ‘H temperature
studies demonstrated that a hydrogen
bonding interaction may well be the
source of the observed downfield shifts, it
was necessary to perform 31P magnetic res-
onance studies on the phospholipids to in-
vestigate other potential mechanisms (i.e.,
exchange, barbiturate interactions with
water) as well as to identify the site of













This intra- or intermolecular complexation
within a micelle may also account for the observed
dipole moment of 2.86 Debye rather than the ex-
pected value of 20 Debye for the dipolar form (27).
Furthermore, this intra- or intermolecular complex-
ation may permit retention of the dipolar ionic char-
acteristics observed in the infrared studies. How-
ever, the ionic state of the phospholipid phosphati-
dylethanolamine is not the major issue of this paper
and does not affect our conclusions in a qualitative
(mechanistic) or quantitative (K0,,) fashion. The
use of small molecules to obtain information on the
molecular structure of larger molecules is the forte
of the NMR method. Perhaps the use of 3P NMR
spectroscopy in conjunction with other forms of spec-
troscopy may resolve the controversy of the nature
of the ionic state of phosphatidylethanolamine.
If the observed ‘H shifts were in fact a
result of chemical exchange, one mecha-
nism might conceivably be exchange of the
barbiturate N -H with the proton of the
P - OH groups, should the phospholipid
exist in a protonated state (i.e., phosphati-
dylethanolamine, cardiolipin). Since it has
been demonstrated by infrared studies (21,
22) that phosphatidylcholine and sphingo-
myelin exist in the ionized state in a Cd4
medium, P - OH exchange for these cases
does not seem reasonable. Furthermore,
for phospholipids in the acid form, the ob-
served direction of the 3’P chemical shifts
also serves to rule out this possibility.
Other mechanisms, such as hydrogen
bonding or exchange between the barbi-
turate N -H and water molecule(s) possi-
bly associated with the phospholipid, re-
main.
If water is added to the phospholipid so
that the water is 5 times the concentra-
tion of the phospholipid, the 3’P peak shifts
upfield by approximately 0.5 ppm. Since
the addition of water to the phospholipid
produces no separate peaks in the 3’P spec-
trum, we can assume that the exchange is
rapid enough so that only an average sig-
nal is observed on the NMR time scale.
Furthermore, if the effects giving rise to
the shift in the “P were purely those of
exchange, an increase in temperature
should produce a change in the linewidth
of the 31P peak, with little or no change in
the “P chemical shift (28). The addition of
barbiturate to the hydrated phospholipid,
if this were an exchange process, should
now cause the 3’P peak to shift downfield
or produce a dramatic change in the “P
linewidth, indicative of a loss of water mol-




Since the addition of barbiturate to
the hydrated phospholipid produces addi-
tional upfield shifting of the 3’P peak (0.5
ppm), this demonstrates that exchange in-
volving water does not contribute to the
observed 31P shift and that the source of ‘H
chemical shifts is not caused totally by
water. The association of barbiturate with
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the phospholipid phosphatidylcholine is
sufficiently strong to occur in the presence
of an excess of water.
The changes in 31P chemical shift as a
result of hydrogen bonding were in an up-
field direction, which might not immedi-
ately be predicted. It should be noted that
the NMR chemical shift of any particular
nucleus is a complex function of the orbital
motion of the surrounding electrons and is
determined by a quantity a-:
Happ = (1 -
where Happ and H0 are the applied and
static magnetic fields, respectively, and a-
is termed the screening constant. The pa-
rameten a- is further defined by
a- = Td + a-,, + (7’
where a-d and a-,. are the diamagnetic and
paramagnetic contributions, respectively,
to the screening constant, and a-’ is the
contribution from neighboring nuclei (29).
The screening constant is also a function of
the energy of the lowest-lying excited state
() (29) and, in certain cases, the geometry
of the molecule (30, 31).
Because of the inherent complexity in
evaluating the effects of hydrogen bonding
upon the screening constant (i.e., , a-’), it
is not possible to predict which term will
predominate and in which direction the
NMR signal corresponding to a given nu-
cleus will shift as a result of hydrogen
bonding (29). Calculations of changes in
proton chemical shifts occurring as a re-
sult of hydrogen bonding lead to the pre-
diction that normally these changes will
occur in a downfield direction (32). How-
ever, these calculations are extremely
complex and the prediction may not apply
to all nuclei (29, 32). In certain cases up-
field chemical shifts as a result of hydro-
gen bonding have been reported (33). ‘4N
resonance studies performed on 5- and 6-
membened nitrogen heterocycles have
shown that proton donors make the ‘4N
resonance shift upfield (33). It is certainly
plausible to interpret the observed 31P up-
field chemical shifts as resulting from hy-
drogen bonding.
The banbiturate-phospholipid studies ne-
ported here were conducted in a weakly
polar medium, CDC13, in order to provide
an environment which would maximize
the possibility of observing the interaction
as well as simulate the internal polarity
of the membrane. Phospholipids form mi-
celles in a weakly polar medium and have
the invented micelle structure; that is, the
polar head groups are in the interior of the
micelle with the fatty acid chains stretch-
ing out in the solvent (34). The use of
chloroform as the solvent system in these
investigations may have presented a ma-
jon accessibility problem for the barbitur-
ate. The barbiturate must penetrate the
fatty acid chains in order to gain accessi-
bility to the phosphate group. The size of
the micelle has been reported as a function
of the concentration and dielectric con-
stant of the medium (35, 36). To remove
the possibility of micellular interactions
contributing to the observed phosphorus
results, a system which has been sug-
gested to be intermediate between C6H6
and water in terms of type of micelle and
molecular aggregation of phosphatidylcho-
line was investigated (36). Phosphatidyl-
choline was reported by Elworthy and
McIntosh (36) to exist as a trimer in meth-
anol, while Kellaway and Saunders (37,
38) reported it to exist as a monomer.
Whether these differences can be attrib-
uted to the experimental methods is not
known; however, it is clear that very little,
if any, aggregation of phosphatidylcholine
occurs in methanol. The addition of meth-
anol to a sample of phosphatidylcholine in
CDC13 produced a chemical shift (approxi-
mately 0.35 ppm) in the phospholipid 31P
peak, showing that the observed 3’P shifts
as a result of barbiturate addition neither
were the result of, non contained sizable
contributions from, micellular interac-
tions. The concentration of methanol re-
quired to produce this effect was 1.0 M,
giving a phospholipid to methanol ratio of
0.11. This change in chemical shift (ap-
proximately 0.35 ppm upfield) observed
upon the addition of methanol was proba-
bly indicative of hydrogen bonding be-
tween the methanol and the phospholipid.
Although the methanol system has been
suggested to represent a midpoint between
aqueous systems and higher alcohols and
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benzene (36), we felt that it was necessary
to evaluate the association of barbiturates
with phospholipids in the presence of wa-
ten. The membrane itself is amphipathic,
with the polar portion of the phospholipids
exposed to water, protein, and a hydropho-
bic region containing the fatty acid chains.
Therefore a model system was required
which would incorporate water into the
phospholipid and maintain the necessary
requirement for the magnetic resonance
experiment (i.e. , well-defined “P signal).
The model of the “wet” phospholipid was
prepared with the water at 5 times the
concentration ofthe phospholipid phospha-
tidylcholine. Phosphatidylcholine has
been shown to contain at least three hy-
dration layers, the first two, tightly bound
layers constituting 4-6 molecules of water
(39-41). Hence, at a ratio of 5 water mole-
cules per molecule of phosphatidylcholine
used in the phospholipid model, one would
roughly expect both hydration layers to be
present. The water is associated with the
polar head group of the phospholipid and
causes changes in micellular asymmetry,
going from oblate ellipsoid to spherical at
high water content (42).
The addition of phenobanbital to the sys-
tem of the hydrated phospholipid produces
an upfield shift in the 3’P peak (approxi-
mately 0.5 ppm), demonstrating that bar-
biturate association occurs in the presence
of an excess of water. This association is
sufficiently strong that the barbiturate
must displace water in order to have ac-
cess to the phosphate group.
The data presented here are consistent
with the conclusion that the N -H of bar-
biturates can form a hydrogen bond with
the phosphate moiety of phospholipids in
nonaqueous media in the presence and ab-
sence of water. Although the PMR results
indicate an electrostatic type of interac-
tion, 3’P and ‘3C magnetic resonance re-
sults were required to distinguish a hydro-
gen bonding interaction from other situa-
tions which might give rise to similar
PMR results (exchange, ion pair forma-
tion) as well as establish the site of inter-
action of the phospholipids. Since barbitu-
rates can bind to phospholipids, perhaps
this is the mechanism by which they are
capable of interacting with membranes.
While it is beyond the scope of this paper
to discuss in detail models dealing with
mechanisms of ion flow in excitable mem-
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